Has the 2011 FDA Guidance on Risk-based Monitoring Impacted SDV Coverage Yet?
Over the past year and a half we have been monitoring the trend towards adoption of risk-based monitoring across the industry, and in particular the move towards reduced source document verification (SDV).
Cambridge, MassachusettsDownload Brochure
-
- Risk-Based Approaches
- ICON Exec Discusses ICONIK MonitoringMore in Risk-Based Monitoring
Articles in this issue
over 13 years ago
Applied Clinical Trials Digital Edition - January 2012over 13 years ago
Risk & Resources to Shape Trial Operationsover 13 years ago
CV Safety for Developersover 13 years ago
Rising Proportion of New and Modified Indication Approvalsover 13 years ago
Risk-based Approach to Monitoringover 13 years ago
Limited Resource Trialsover 13 years ago
Imaging Pharmacovigilance Needs Overhaulover 13 years ago
Refined Safety Assessmentsover 13 years ago
Biotech's Long Road to Savvyover 13 years ago
Imperatives to Share Trial Results with Volunteersover 13 years ago
Snapshot Shows Targeted Site Monitoring Trendover 13 years ago
A Race to the Finish for CTs in Europe?over 13 years ago
Emerging Opportunity in GuatemalaNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Using AI Trial-Matching Tools to Accelerate Patient Access
September 8th 2025
- How AI Can Help Physicians Identify Eligible Trials Faster
September 5th 2025